Skip to content
VC FundPuts its own capital into companiesInactiveLAST VERIFIED Oct 2026 · 6 SOURCES

EMBL Ventures

Also known as EMBL Ventures GmbH, EMBL Technology Fund, EMBL Technology Fund II, ETF II

Heidelberg life-science VC manager (EMBL Ventures GmbH) of the EMBL Technology Funds; no new investment seen since about 2021, site now compromised; treated as inactive.

Heidelberg life-science VC manager linked to the European Molecular Biology Laboratory (EMBL); not EMBL itself (an intergovernmental research organisation) nor EMBLEM, EMBL's technology-transfer company.

HEADQUARTERS
Heidelberg, Germany
FOUNDED
—
AUM
—
OUTSIDE CAPITAL
—
TEAM LISTED
2 people

Focus

STAGES
SeedSeries A
SECTORS
Biotech & Life SciencesHealthTech
ASSET MIX
Venture capital
GEOGRAPHY
Europe

Overview

EMBL Ventures GmbH is a Heidelberg-based venture capital manager that invests throughout Europe in life-science companies built on new therapeutic modalities and pharmaceuticals, next-generation enabling platforms, and diagnostics and medical devices. It offers portfolio companies access to the European Molecular Biology Laboratory (EMBL) network. It manages the EMBL Technology Fund (ETF), described by EMBLEM, EMBL's technology-transfer arm, as an early-stage fund with €120m under management backed by institutional and private investors including EMBLEM. Its news page tracks portfolio companies such as Topas Therapeutics, Allecra Therapeutics, Immatics and Crescendo Biologics.

Investment thesis

Company building in European life sciences: new therapeutic treatment modalities and pharmaceuticals, next-generation enabling technology platforms, and diagnostics and medical devices, with hands-on support and access to EMBL.

PORTFOLIO (5)

  • ImmaticsNOTABLE
    Biotech & Life Sciences · IPO
  • Topas Therapeutics
    Biotech & Life Sciences
  • Allecra Therapeutics
    Biotech & Life Sciences
  • Crescendo Biologics
    Biotech & Life Sciences
  • Amphivena
    Biotech & Life Sciences

People

  • Dr. Stefan Herr
    Managing Director (Geschäftsführer) · source
  • Dr. Frank Mühlenbeck
    Managing Director (Geschäftsführer) · source

Links

Frequently asked questions

EMBL Ventures is a VC fund based in Heidelberg, Germany.

Yes. EMBL Ventures invests its own capital in private companies.

EMBL Ventures invests at Seed and Series A stages in Biotech & Life Sciences and HealthTech.

Key people at EMBL Ventures include Dr. Stefan Herr (Managing Director (Geschäftsführer)) and Dr. Frank Mühlenbeck (Managing Director (Geschäftsführer)).

EMBL Ventures's investments include Immatics, Topas Therapeutics, Allecra Therapeutics, Crescendo Biologics and Amphivena.